We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Non-Invasive Stool Test to Diagnose Endometriosis and Help Reduce Disease Progression

By LabMedica International staff writers
Posted on 14 Oct 2024

Endometriosis, a painful condition impacting nearly 200 million women globally, occurs when tissue similar to the lining of the uterus grows outside its usual location, such as on the intestines or the abdominal lining. More...

This abnormal growth typically leads to bleeding, pain, inflammation, and infertility. On average, it takes about seven years to diagnose endometriosis, and it is often misdiagnosed as a bowel condition. The delays in diagnosis, coupled with the reliance on invasive diagnostic methods and ineffective treatments, highlight the urgent need for better management of this condition. Now, researchers have made promising discoveries that could pave the way for a non-invasive stool test and a new treatment option for endometriosis.

Earlier research conducted on mice by scientists at Baylor College of Medicine (Houston, TX, USA) and their collaborators indicated that the microbiome—communities of bacteria within the body—and their metabolites may play a role in the progression of endometriosis. In the current study, researchers focused on the microbiome's involvement by comparing the bacteria and metabolites in the stools of women with endometriosis to those of healthy women. They found notable differences between the two groups. Specifically, they identified a combination of bacterial metabolites unique to women with endometriosis, including 4-hydroxyindole, a compound produced by beneficial bacteria. Women with endometriosis had lower levels of this metabolite compared to those without the condition. Additionally, extensive research revealed that administering 4-hydroxyindole to animal models of endometriosis effectively prevented the onset and progression of inflammation and pain associated with the disease.

The findings, published in the journal Med, suggest that the stool metabolites found in women with endometriosis could form the basis for a non-invasive diagnostic test, as well as a potential therapeutic approach to slow disease progression. Interestingly, the metabolite profile discovered in endometriosis patients mirrors that seen in inflammatory bowel disease (IBD), hinting at a possible link between the two conditions. This research supports the idea that the microbiome plays a role in both endometriosis and IBD. The team continues to work on developing a non-invasive stool test for diagnosing endometriosis and is conducting further studies to assess the safety and effectiveness of 4-hydroxyindole as a potential treatment for the condition.

“These findings are very exciting,” said Dr. Chandni Talwar from Baylor. “There are studies in animal models of the disease that have shown specific bacterial metabolite signatures associated with endometriosis. Our study is the first to discover a unique metabolite profile linked to human endometriosis, which brings us closer to better understanding the human condition and potentially identifying better ways to manage it.”


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Hemodynamic System Monitor
OptoMonitor
New
Blood Glucose Test Strip
AutoSense Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The VeraBIND Tau assay is a novel blood test that identifies the presence of active tau pathology (Photo courtesy of 123RF)

First Blood-Based Test Measures Key Alzheimer's Biomarker in Asymptomatic and Symptomatic Individuals

Alzheimer’s disease (AD), the sixth leading cause of death in the United States, affects an estimated 7.2 million Americans aged 65 or older. Current diagnostic methods for AD are often invasive, expensive,... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.